AI Insights · Timothy · January 2022
Top 5 Health and Fitness Apps in the Middle East Q4 2021
Explore the performance of the top 5 health and fitness apps on a unified platform in the Middle East during Q4 2021, highlighting key metrics such as weekly downloads, revenue, and active users.
During the fourth quarter of 2021, the top 5 health and fitness apps in the Middle East exhibited notable trends in downloads, revenue, and active users. The data, sourced from Sensor Tower, provides valuable insights into the app performance in this region.
MyFitnessPal: Calorie Counter experienced a varied trend in weekly revenue, peaking at approximately $18.4K in the first week of November. Weekly downloads saw a decline from 9.8K in early October to around 7.2K by the end of December. Active users witnessed fluctuations, starting at 236.6K and ending the quarter at 233.5K.
Headspace: Sleep & Meditation showed an increase in weekly revenue, reaching $12.3K in the last week of December. Downloads were relatively stable, with a notable spike to 3.9K in early December. Active users also increased to 13.5K in the same period before dropping to 7.7K by the end of the month.
Flo Period & Pregnancy Tracker demonstrated consistent growth in revenue, peaking at $12.5K in late December. Downloads showed an upward trend, starting at 8.9K and reaching 12.9K by the end of the quarter. Active users remained robust, with numbers fluctuating between 347K and 373K.
Calm had steady weekly revenue, peaking at $10.5K in mid-October. Downloads experienced a significant increase to 5.7K in early December. Active users saw a rise from 38.7K at the start of the quarter to 45.8K in early December, before ending the quarter at 36.6K.
Workout Planner Muscle Booster showed varying revenue trends, peaking at $10.5K in the last week of December. Downloads fluctuated, with a notable peak at 19.4K in mid-December. Active users saw substantial growth, starting at 15.5K and reaching 36.4K by mid-December.
For more detailed insights and data, visit Sensor Tower.